Key insights
- The post discusses growing concerns about downside risk in private credit, highlighting potential issues like redemption limits in semi-liquid funds, repricing of deals, and stress in sponsor-backed software. It questions whether the risk is primarily about liquidity or deteriorating credit quality. The discussion also points to specific areas of concern, including BDCs, direct lending strategies, software and healthcare sectors, and vulnerable deal structures like unitranche and covenant-lite loans. This could lead to a moderate negative impact on US equities if private credit issues escalate and spill over into broader markets.
Trying to get smarter on where people see real downside risk building in private credit right now.
Between semi-liquid funds hitting redemption limits, some deals getting repriced wider, and what looks like growing stress in sponsor-backed software, it feels like we might be early in a broader shift. At the same time, a lot of portfolios are still being marked pretty optimistically.
Curious where folks are actually bearish:
-Specific funds or vehicles (BDCs, interval funds, evergreen credit funds)
-Particular managers or strategies (direct lending vs asset-based vs opportunistic)
-Sectors showing the most cracks (software, healthcare roll-ups, etc.)
-Structures that feel most vulnerable (unitranche, covenant-lite, PIK-heavy deals)
-Anything showing up in secondaries or marks that isn’t reflected in NAVs yet
Also interested in what people think is not being talked about enough. Is the risk more about liquidity, or actual credit quality starting to turn?
Would especially appreciate perspectives from anyone seeing this from the inside (LPs, lenders, restructuring folks, etc.).